NFKB1 and prostate cancer: In light of our findings, it is important to acknowledge that recent evidence shows that miR-210 overexpression drives NF-κB transcriptional responses and, thereby, is upstream of NF-κB signaling activation, albeit in immortalized PC-3 prostate cancer cells [81].